I agree. Over the last couple of years but especially the last 12 months the articles on BRN have dramatically changed. It has moved from the potential of SNN/Akida to actual application development. Some of us knew from experience or related experience it was going to take years to become commercial because of the way companies are cautious in implementing cutting edge tech into their business. Get it wrong and the consequences are horrendous for their company and their own future job prospects.
IMO, the ecosystem around SNN in the last few years hasn't been fully developed to support it. I think it has finally caught up allowing Akida to be commercialised in the short term. When I bought in 2021, my educated guess was 2025. We'll soon see.
I don't only have the trolls on ignore but the idiots who keep replying to them giving them oxygen. Cuts down the posts you go through by 75%.
- Forums
- ASX - By Stock
- BRN
- 2025 BrainChip Discussion
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

2025 BrainChip Discussion, page-4785
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 0.200 |
32 | 1165519 | 0.195 |
40 | 1677173 | 0.190 |
41 | 1955162 | 0.185 |
68 | 1294871 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 207258 | 8 |
0.210 | 1889570 | 35 |
0.215 | 1070502 | 19 |
0.220 | 1267378 | 34 |
0.225 | 990448 | 20 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online